Survival update from a phase II trial of fulvestrant ('Faslodex®') in tamoxifen-resistant breast cancer patients

Breast Cancer Research and Treatment

Volumn 69, Issue 3, 2001, Pages 289-

  Robertson, J F R ^a   Howell, A ^a   Owers, R ^a   Cheung, K L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0242664446     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)